A Swiss healthcare technology company that builds a cloud-based, AI-powered software platform called SOPHiA DDM, which hospitals and laboratories use to analyze complex genomic data for diagnosing cancer and rare diseases. It was founded in 2011 as a startup at the École Polytechnique Fédérale de Lausanne (EPFL) in Switzerland by Dr. Jurgi Camblong, Prof. Lars Steinmetz, and Dr. Pierre Hutter. The name comes from the Ancient Greek word "sophia," meaning wisdom — the same root as "philosophy" — reflecting the founders' goal of turning raw DNA data into clinical insight.
Select a row to see that insider’s individual transactions. † Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 6 months: -349.8K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.